investigational new drug

in·ves·ti·ga·tion·al new drug in-.ves-ti-'gā-shə-nəl- n a drug that has not been approved for general use by the Food and Drug Administration but is under investigation in clinical trials regarding its safety and efficacy first by clinical investigators and then by practicing physicians using subjects who have given informed consent to participate abbr. IND called also investigational drug

Medical dictionary. 2011.

Look at other dictionaries:

  • Investigational new drug — The United States Food and Drug Administration s investigational new drug (IND) program is the means by which a pharmaceutical company obtains permission to ship an experimental drug across state lines (usually to clinical investigators) before a …   Wikipedia

  • investigational new drug — medication that has received FDA approval for clinical trials in humans (Medicine), IND …   English contemporary dictionary

  • Compassionate Investigational New Drug program — The Compassionate Investigational New Drug program, or Compassionate IND, is a United States Federal Government ran Investigational New Drug program that allows a limited number of patients to use medical marijuana grown at the University of… …   Wikipedia

  • New Drug Application — Regulation of therapeutic goods in the United States Prescription drugs Over the counter d …   Wikipedia

  • New drug application — The New Drug Application (NDA) is the vehicle in the United States through which drug sponsors formally propose that the FDA approve a new pharmaceutical for sale and marketing. The goals of the NDA are to provide enough information to permit FDA …   Wikipedia

  • New Drug Application — Die New Drug Application (NDA) stellt den Antrag auf Arzneimittelzulassung bei der US amerikanischen Behörde für Lebensmittel und Arzneimittelsicherheit (FDA) dar, welchen Arzneimittelhersteller stellen müssen, um eine Marktzulassung zu erhalten …   Deutsch Wikipedia

  • Drug development — Drug research redirects here. For the journal, see Drug Research (journal). Drug development is a blanket term used to define the process of bringing a new drug to the market once a lead compound has been identified through the process of drug… …   Wikipedia

  • Drug Price Competition and Patent Term Restoration Act — Acronym Hatch Waxman amendments Citations Codification …   Wikipedia

  • Drug Master File — or DMF is a document prepared by a pharmaceutical manufacturer and submitted solely at its discretion to the appropriate regulatory authority in the intended drug market. There is no regulatory requirement to file a DMF. However, the document… …   Wikipedia

  • investigational — adjective Date: 1905 1. of or relating to investigation < investigational activities > 2. relating to or being a drug or medical procedure that is not approved for general use but is under investigation in clinical trials regarding its safety and …   New Collegiate Dictionary

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”

We are using cookies for the best presentation of our site. Continuing to use this site, you agree with this.